Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
SwitzerlandIPO:
09 April 2019Website:
http://www.alcon.comNext earnings report:
15 November 2024Last dividends:
14 May 2024Next dividends:
N/APrice
after hours | 49 min agoAnalysts recommendations
Institutional Ownership
ALC Latest News
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (TSX: ALC) today announced it will report its financial results for the three and nine months ended September 30, 2024 before market open on November 4, 2024. The Company's third quarter earnings release and full financial results will be available on the Company's website and on SEDAR. Algoma Central Corporation is a global provider of marine transportation that owns and operates dry and liquid bulk carriers, serving markets.
Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.
Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.
Bausch + Lomb stock surged Monday — briefly breaking out — on a report the company is working with advisors to explore a potential sale.
Alcon CEO David Endicott comments on the company's second-quarter results.
Alcon Inc. ALC reported mixed second-quarter results, after the closing bell on Tuesday.
Alcon (ALC) delivers impressive growth in Implantables and Contact Lenses in the second quarter of 2024.
Alcon Inc. (NYSE:ALC ) Q2 2024 Earnings Conference Call August 21, 2024 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim Stonesifer - Chief Financial Officer Conference Call Participants Jeff Johnson - Baird Graham Doyle - UBS Veronika Dubajova - Citi Ryan Zimmerman - BTIG David Adlington - JPMorgan Patrick Wood - Morgan Stanley Jack Reynolds-Clark - RBC Capital Markets David Saxon - Needham & Company Anthony Petrone - Mizuho Group Larry Biegelsen - Wells Fargo Michael Sarcone - Jefferies Issie Kirby - Redburn Atlantic Richard Felton - Goldman Sachs Tom Stephan - Stifel Steven Lichtman - Oppenheimer & Company Brett Fishbin - KeyBanc Capital Markets Operator Greetings and welcome to the Alcon Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alcon (ALC) is witnessing growth in its over-the-counter portfolio, driven by favorable pricing and a sustained family of products.
What type of business is Alcon?
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
What sector is Alcon in?
Alcon is in the Healthcare sector
What industry is Alcon in?
Alcon is in the Medical Instruments & Supplies industry
What country is Alcon from?
Alcon is headquartered in Switzerland
When did Alcon go public?
Alcon initial public offering (IPO) was on 09 April 2019
What is Alcon website?
https://www.alcon.com
Is Alcon in the S&P 500?
No, Alcon is not included in the S&P 500 index
Is Alcon in the NASDAQ 100?
No, Alcon is not included in the NASDAQ 100 index
Is Alcon in the Dow Jones?
No, Alcon is not included in the Dow Jones index
When was Alcon the previous earnings report?
No data
When does Alcon earnings report?
The next expected earnings date for Alcon is 15 November 2024